| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.005 |